Shandong Weigao Group Medical Polymer (HKG:1066) recorded a revenue of around 3.35 billion yuan in the first quarter, up about 5.3% from a year prior, according to a Friday Hong Kong bourse filing.
Of the total, the medical device and pharma packaging segments achieved high single-digit increases.
The medical device firm's orthopaedic and interventional niches logged low single-digit increases, while the blood management niche saw a mid-single-digit decrease.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.